baber/WOPTO huggingface dataset:
Patent AT-E333126-T1 (AT)
Inventor: SCHNEIDER MATTHIAS
IPC: G06Q20/00
Filed: 2002-01-15
Granted: 2006-08-15
Abstract: The invention relates to a system for vending prepaid products, comprising a central data bank (2) and at least one vending device (4), provided with a data memory, that can be interlinked via a telecommunication link (3). The aim of the invention is to create a uniform vending platform. To this end, the prepaid products are stored as code words in the central data bank (2) and are transferred to the data memory of the vending device (4) via the telecommunication link (3). The code words are combined to data packages with a predetermined, preferably small number of code words. The vending device (4) outputs a code word to the client after sale and feedbacks the number of code words sold to the central data bank (2) after one or several sales. The central data bank (2) monitors the number of code words still available in the vending device (4) and transmits a new data package with new code words when the number of code words falls below a predetermined value.
Patent AT-E468885-T1 (AT)
Inventor: HERLEIKSON EARL
IPC: A61N1/04
Filed: 2002-03-26
Granted: 2010-06-15
Abstract: A system for identifying electrodes connected to a defibrillator. At least two electrodes with at least one connecting pin operatively connected to each electrode. Each connecting pin includes at least one pair of contacts. A receptacle receives each connecting pin. Circuitry is operatively connected to the receptacle for detecting shorting of the contacts to determine a type of electrode connected to the receptacle.
Patent AT-E530146-T1 (AT)
Inventor: MICHELSON GARY KARLIN
IPC: A61B17/02
Filed: 2002-03-26
Granted: 2011-11-15
Abstract: Intervertebral fusion implant (900) for insertion from an anterior approach as well as instruments for inserting and removing the implant. 
The implant has an open trailing end (902), a leading end (904), a base (905) proximate the leading end and arms (909,910) extending from the base. An expander (920) is provided in the implant to expand the arms to an expanded state.
Patent AT-E298940-T1 (AT)
Inventor: PRICE JONATHAN H V
IPC: G02B6/00
Filed: 2002-04-10
Granted: 2005-07-15
Abstract: A source of optical pulses, comprises an optical source operable to generate ultrashort optical pulses at a first wavelength; and an optical fiber amplifier comprising an optical fiber having a core containing a dopant to provide optical gain at the first wavelength and anomalous dispersion over a wavelength range including the first wavelength and a second wavelength. The optical fiber receives the ultrashort optical pulses, amplifies the ultrashort optical pulses, and alters the wavelength of the ultrashort optical pulses to at least the second wavelength by the soliton-self-frequency shifting effect. Microstructured and/or tapered fibers can be used to provide the required dispersion characteristics. Pulses can be generated in one of three spectral regimes-monocolor solitons, multicolor solitons and continuous broadband spectra by adjusting the energy of the optical pulses, and tunability can be achieved by varying the power of pump light provided to the amplifier.
Patent AT-E447921-T1 (AT)
Inventor: BARTLETT ALAN
IPC: A61G7/00
Filed: 2002-03-27
Granted: 2009-11-15
Abstract: A prone positioning therapeutic bed (10) comprises a base frame (16) and a patient support platform (20) rotatably mounted on the base frame (16) for rotational movement about a longitudinal rotational axis and a drive system for rotating the patient support platform on the base frame. A special head restraint apparatus (50) maintains proper patient alignment during rotation. A weight monitoring system monitors a patient's weight over time. A touch screen user interface provides a programmable therapy settings and displays statistics about past treatment. Circuitry is provided to minimise the risk that the failure of any single device or software program could endanger a patient. A "CPR" button is provided to arrest any program of therapy and return the patient support platform to a supine position. <IMAGE>
Patent AT-E407204-T1 (AT)
Inventor: ABURATANI HIROYUKI
IPC: A61K39/395
Filed: 2002-06-21
Granted: 2008-09-15
Abstract: Cell-proliferation inhibitors contain anti-glypican 3 antibody as active ingredient, are new. An independent claim is also included for an antibody with cytotoxicity. ACTIVITY : Cytostatic. No Biological data is given. MECHANISM OF ACTION : None given in source material.
Patent AT-E447298-T1 (AT)
Inventor: REDERT P-A
Filed: 2002-06-25
Granted: 2009-11-15
Abstract: Disclosed in an image processing unit for generating, based on a plurality of input images, a first output image and a second output image, to be displayed on a stereoscopic display device, wherein a stereoscopic image and a monoscopic image can be displayed. The image processing unit including an offset calculator designed to calculate an offset image based on a first one of the input images, an addition unit designed to calculate the first output image by adding the offset image with a second one of the input images and a subtraction unit designed to calculate the second output image by subtracting the offset image from the second one of the input images.
Patent AT-E315022-T1 (AT)
Inventor: ELWORTHY TODD RICHARD
IPC: C02F1/00
Filed: 2002-07-08
Granted: 2006-02-15
Abstract: This invention relates to compounds which are generally EP<SUB>4 </SUB>receptor agonists and which are represented by Formula I: wherein A is a -CH<SUB>2</SUB>-CH<SUB>2</SUB>-, or -CH-CH-; B is absent, an aryl, or heteroaryl group; R<SUP>1 </SUP>is alkyl, alkenyl, alkynyl, cycloalkylalkyl, heterocyclylalkyl, aryl, arylalkyl or heteroaryl, when B is aryl or heteroaryl and R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>are not simultaneously hydrogen, or R<SUP>1 </SUP>is heterocyclylalkyl, aryl, or heteroaryl when B is absent and R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>are simultaneously hydrogen; and the other substituents are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.
Patent AT-E414791-T1 (AT)
Inventor: BERLIN KURT
IPC: C12Q1/68
Filed: 2002-10-04
Granted: 2008-12-15
Abstract: The invention relates to a method for detecting the methylation status in DNA samples. According to the invention, a DNA methyl transferase and a labeled S-adenosylmethionine derivative allow a detectable label to be covalently bonded to the DNA, in accordance with the respective methylation status of the DNA sample.
Patent AT-E341109-T1 (AT)
Inventor: TRYER MARK C
IPC: G08B13/24
Filed: 2002-07-31
Granted: 2006-10-15
Abstract: An EAS antenna having uniform antenna thickness along the antenna height is provided. The antenna is contains at least two overlapping coils where the individual coil cross-sections are variable with respect to the circumference. If the individual coil thickness is halved at the overlap, the antenna will have uniform thickness along the antenna height. This is accomplished by reducing the number of wire turns per layer along one or more sections of the coil, and simultaneously increasing the number of wire layers on the same sections.
Patent AT-E335602-T1 (AT)
Inventor: PENTTINEN TAPANI
IPC: B65D77/20
Filed: 2002-10-15
Granted: 2006-09-15
Abstract: The invention relates to a lid (1) that can be heat-sealed to the opening of a package (2) and peeled off as the package is opened. In addition, the invention comprises methods for manufacturing such a lid and a package sealed with the lid, and also a sealed package equipped with a lid. The lid (1) consists of a fibrous material layer (6), whichmay be paper or cardboard, a polymer oxygen-barrier layer (7), suitable materials of which are polyethylene terephthalate (PET), ethylene vinyl alcohol copolymer (EVOH) or polyamide (PA), and a polymer heat-seal layer (8). In accordance with the invention, the heat-seal layer (8) combines ethylene methyl acrylate copolymer (EMA), ethylene vinyl acetate copolymer (EVA) and polyamide wax, adherence of the heat-seal layer directly to the oxygen-barrier layer (7) having been allowed without any intermediate binder. During the manufacture of the lid, the oxygen-barrier and heat-seal layers (7, 8) can be applied onto paper or cardboard by coextrusion. The packages equipped with a lid in accordance with the invention comprises boxes, cups or goblets, for instance, into which foodstuffs, such as drinks, nutrients fats or ready-made foods have been packaged.
Patent AT-E480770-T1 (AT)
Inventor: KRIEG WOLFGANG
IPC: G01N29/07
Filed: 2003-01-22
Granted: 2010-09-15
Abstract: Inspecting pipe wall of pipeline for defects involves controlling a portion of virtual sensors to irradiate ultrasound signals into the pipe wall at irradiation angle(s) which is inclined to a normal to the pipe wall, receiving ultrasound signals reflected by bordering surfaces of the pipe wall in the virtual sensors, and evaluating the received signals from differing bordering surfaces.  Inspecting pipe wall of pipeline for defects involves: (a) introducing measuring sensors into the pipeline, each measuring sensor (16) comprising an array of controllable sensor elements; (b) defining virtual sensors, each virtual sensors comprising an array of neighboring sensor elements; (c) controlling at least a portion of the virtual sensors to irradiate ultrasound signals into the pipe wall at irradiation angle(s) which is inclined to a normal to the pipe wall; (d) receiving ultrasound signals reflected by bordering surfaces of the pipe wall in at least a portion of the virtual sensors; and (e) evaluating the received signals from differing bordering surfaces to determine pipe wall defects. An Independent claim is also included for a device for inspecting the pipe wall of a pipeline for defects.
Patent AT-E375194-T1 (AT)
Inventor: JANTSCH UWE
IPC: B01D67/00
Filed: 2003-03-29
Granted: 2007-10-15
Abstract: Composite membrane (1) comprises a layer system consisting of a rigid non-self supporting non-metallic inorganic diffusion barrier layer (1b) and hydrogen-permeable non-porous metallic membrane layers (1c) arranged on a flexible metallic substrate (1a).  Preferred Features: The diffusion barrier layer is arranged between the substrate and one membrane layer and is formed as a single layer. The single layer is open-pored and/or has micro-tears. The substrate has an open porosity in the region of 15-60%. At least one of the membrane layers is galvanically deposited on the surface of the diffusion barrier layer facing away from the substrate.  An Independent claim is also included for a process for the production of the composite membrane.
Patent AT-E365261-T1 (AT)
Inventor: GRUENDLER DANIEL
IPC: E05C9/00
Filed: 2003-04-02
Granted: 2007-07-15
Abstract: A stay for a door or window which allows partial opening with maximum security has a slider moving along the stay and with a locking catch fitted to the stay and moving along a slot in the slider. The locking catch is spring loaded axially and/or the stay has elasticity in the axial direction of the catch. The latter is achieved by a profiled section of the stay to provide a set amount of elasticity.
Patent AT-E329896-T1 (AT)
Inventor: YOSHIDA YASUO
IPC: C07C205/26
Filed: 1999-08-11
Granted: 2006-07-15
Abstract: The main tasks of the present invention are to provide, from a raw material which is industrially inexpensive and easy to procure, an N-cyclopropyl-2-difluoromethoxy-3-halogenoaniline which is an important intermediate in production of a quinolonecarboxylic acid having a cyclopropyl group at the 1-position, an isoindolinyl group at the 7-position and a difluoromethoxy group at the 8-position, useful as a synthetic antibacterial agent; and an intermediate used for production thereof. <??>The present invention provides:  a difluoromethoxybenzene derivative represented by the following formula (1): <CHEM> wherein X is a halogen atom and Y is a nitro group or an amino group; an N-(1-alkoxycyclopropyl)-2-difluoromethoxy-3-halogenoaniline derivative represented by the following formula (2): <CHEM> wherein X is a halogen atom and R<1> is a lower alkyl group; and an N-cyclopropyl-2-difluoromethoxy-3-halogeno-aniline derivative represented by the following formula (3): <CHEM> wherein X is a halogen atom and R is a hydrogen atom or a 2,2-di(alkoxycarbonyl)ethylene group represented by the following formula (4): -CH=C(CO 2R<2>)2 (wherein R<2> is a lower alkyl group).
Patent AT-E316801-T1 (AT)
Inventor: GRUNDEI DR HANS
IPC: A61L27/00
Filed: 2003-11-07
Granted: 2006-02-15
Abstract: Joint prosthesis comprises a part with a metal core that is coated with a glass ceramic in areas in rolling and/or sliding contact with another part of the joint. The glass ceramic has one of three defined oxide compositions, e.g. (wt.%): silicon (45-50), aluminum (15-20), zirconium (8-12), potassium (8), sodium (7.5), calcium (2.5), titanium (1.5) and manganese(IV), iron(III) and/or cobalt(III) (up to 12.5). Joint prosthesis comprises a part with a metal core that is coated with a glass ceramic in areas in rolling and/or sliding contact with another part of the joint. The glass ceramic has one of the following oxide compositions (wt.%): (A) silicon (45-50), aluminum (15-20), zirconium (8-12), potassium (8), sodium (7.5), calcium (2.5), titanium (1.5) and manganese(IV), iron(III) and/or cobalt(III) (up to 12.5); (B) silicon (35-55), aluminum (15-25), titanium (10-14), sodium (7.5), potassium (7), zirconium (1-5), calcium (0.5) and manganese(IV), iron(III), cobalt(III) and/or copper(II) (up to 24); or (C) silicon (50-60), aluminum (5-10), zirconium (5-10), sodium (8), calcium (6), titanium (3-5), potassium (2), antimony(V) (0.5) and manganese(IV), iron(III), cobalt(III), copper(II) and/or cerium(IV) (up to 20.5).
Patent AT-E430857-T1 (AT)
Inventor: ERRANI DEO
IPC: E05B15/02
Filed: 2003-12-02
Granted: 2009-05-15
Abstract: A selvage for electric or mechanical lock with a pivot (7) for a pawl engagement system, comprising a rear fixing plate (2) in which two links (4) with through holes (5) are pivoted coaxially and independently. The holes (5) rotatably accommodate the ends of the pivot (7). The diameter of the ends (8) of the pivot (7) is smaller than the diameter of the holes (5), producing a mechanical play (9) that allows the pivot (7) to tilt its own axis with respect to the pivoting axis of the links (4). <IMAGE>
Patent AT-E454485-T1 (AT)
Inventor: HANLON THOMAS R
IPC: C23C22/07
Filed: 2003-08-29
Granted: 2010-01-15
Abstract: A non-chromate protective coating and coating solution useful for coating iron and iron alloys, particularly steel, includes V2O5, Ce2(MoO4)3 or SrWO4 as a corrosion inhibitive component.
Patent AT-E517593-T1 (AT)
Inventor: ZANOTTI MARIO
IPC: A61F7/00
Filed: 2003-10-03
Granted: 2011-08-15
Abstract: Thermal exchange apparatus (1) comprising a primary circuit for circulating a primary thermal carrier fluid, said primary circuit being enclosed in a main body (2) and comprising at least one compressor, means for imposing a temperature change on said primary thermal carrier fluid, an expansion member for said primary thermal carrier fluid and a first heat exchanger, at which said primary thermal carrier fluid undergoes a temperature change opposite in sign. A secondary circuit for circulating a secondary thermal carrier fluid is thermally coupled with said primary circuit at said first heat exchanger, said secondary circuit comprising at least one second heat exchanger (4, 4') between said secondary thermal carrier fluid and an external body, said second heat exchanger (4, 4') being external to said main body (2). <??>The thermal exchange apparatus (1) allows cold and/or heat generated in the main body of the apparatus to be transferred in a simple manner and with notable flexibility of use, to apply them to an external body even at a distance from said main body (2). Such an apparatus has preferred use for the application of thermal treatments on animals or people. <IMAGE>
Patent AT-E331895-T1 (AT)
Inventor: SCHROEDER DIRK
IPC: F16B7/06
Filed: 2003-02-17
Granted: 2006-07-15
Abstract: Disclosed is a fork head (1) comprising an abutment section (3) for attaching a rod-type or rope-type tensioning element thereto. Two parallel brackets (7, 8) are arranged in an extension of the abutment section (3). An insertion slot (9) is disposed between said brackets (7, 8) which are penetrated by aligned cross holes (10, 11) receiving a bolt. The faces (14, 15) of the brackets (7, 8), which are opposite the abutment section (3), are bent in the shape of a spherical segment. Longitudinal external recesses (20, 21) which are curved in a concave manner and widen and deepen from the abutment section (3) towards the cross holes (10, 11) are arranged on the outer surfaces (18, 19) of the brackets (7, 8). The cross holes (10, 11) extend into frontal ring-shaped indentations (22, 23) of the brackets (7, 8). Locking disks are placed in the indentations (22, 23) for fixing the bolt, said locking disks being secured by a securing element in the form of countersunk head screws.
Patent AT-E369241-T1 (AT)
Inventor: KAMPRATH AXEL
IPC: B29C31/04
Filed: 2003-04-08
Granted: 2007-08-15
Abstract: In the method for producing the moulded bonded foam article a binder is applied onto the foam particles, the obtained mixture is introduced in a mould (14) while generating a flow of gas through the mould cavity (10) to compress the mixture, the inlet opening (13) is closed, and the binder is allowed to set. In order to enable a better control of the density distribution in the mould cavity (10), the flow of gas is controlled to reach for a predetermined period of time a minimum flow rate, expressed in normal m<3> of gas per minute, of at least 500 times the inner volume V, expressed in m<3>, of the mould cavity, and/or a mould (14) with a larger inlet opening (13) is used, more particularly an open mould, the inlet opening of which has a surface area which is at least equal to 30% of the maximum cross-sectional surface area of the mould cavity measured in a plane parallel to the inlet opening, and/or the mixture is introduced in a stream having a surface area smaller than the surface area of the inlet opening. <IMAGE>
Patent AT-E534448-T1 (AT)
Inventor: JOHNSON BUSTER
IPC: A61M1/00
Filed: 2003-03-24
Granted: 2011-12-15
Abstract: The invention described herein is drawn to a hollow cylindrical filter for use with a suction canister including a first portion having an open end and a first wall thickness, a second portion having a closed end and second wall thickness less than said first wall thickness, and an elongate central chamber having a substantially uniform diameter along its length. The filter is composed of a composite material including a porous plastic material and material adapted to increase the viscosity of a liquid coming into contact therewith. The filter is constructed to accommodate the changes associated with air flow velocity and shear force across the filter material as the fluid level in the canister rises, and automatically shuts off the vacuum to the interior environment of the suction canister. The invention also includes a filter system including such a filter in combination with a filter shield which accommodates the filter within and attaches to, or is alternatively integrated with, the underside of a suction canister lid.
Patent AT-E468156-T1 (AT)
Inventor: SIMONSEN JAN
IPC: A61B18/18
Filed: 2003-05-27
Granted: 2010-06-15
Abstract: The present invention relates to a therapeutic treatment device for non-invasive treatment of skin-disorders such as discoloring, acne, wrinkles, blood vessels, cellulite and stretch marks. Furthermore the device can be used to remove unwanted hair, softening of scar tissue and other skin-disorders. The therapeutic treatment device comprising one or more light sources having a wide range of wavelengths, which can be selected according to the required skin treatment, with a controlled pulse band width and a high enough energy density for application to and in the affected area.
Patent AT-E507792-T1 (AT)
Inventor: OCEL JON
IPC: A61B18/14
Filed: 2003-01-14
Granted: 2011-05-15
Abstract: An instrument including an elongated shaft and a non-conductive handle is disclosed. The shaft defines a proximal section and a distal section. The distal section forms an electrically conductive tip. Further, the shaft is adapted to be transitionable from a straight state to a first bent state. The shaft is capable of independently maintaining the distinct shapes associated with the straight state and the first bent state. The handle is rigidly coupled to the proximal section of the shaft. The instrument is useful for epicardial pacing and/or mapping of the heart for temporary pacing on a beating heart, for optimizing the placement of ventricular leads for the treatment of patients with congestive heart failure and ventricular dysynchrony and/or for use in surgical ablation procedures.
Patent AT-E324478-T1 (AT)
Inventor: BOURBON ERIC
IPC: D02G3/40
Filed: 2003-01-30
Granted: 2006-05-15
Abstract: A sheathed yarn having a natural appearance comprises a core yarn and a sheath which is made from a thermoplastic material. The thermoplastic material of the sheath comprises less than 20 wt.-% of staple fibers, especially of natural origin. The sheathed yarn exhibits excellent mechanical properties and usage properties such as fire resistance, weatherability, resistance to sunshine, and an external appearance generating physically pleasant visual, tactile and olfactory sensations.
Patent AT-E298745-T1 (AT)
Inventor: MEESE CLAUS
IPC: A61K31/403
Filed: 2003-02-27
Granted: 2005-07-15
Abstract: New azaspiro compounds (I) useful as medicaments. Azaspiro compounds of formula (I) and their tautomers and salts useful as medicaments are new; [Image] X1, X2H; X1+X2S or NOH; R1H; R2H, OH, CHO, COOH, halo, SH, sulfonyl, amino, amido or R7Q1; R3H, OH, amino or R8Q2; Z : 4-to 10-membered C-bonded ring that contains 0-2 O or S atoms and is optionally substituted with OH, CHO, COOH, halo, SH, sulfonyl, amino, amido or R9Q3; R7-R9A, 3-6C cycloalkyl, 2-5C alkenyl, 2-5C alkynyl, OA, COA, COOA, SA, NHA, SOA, SO2A, A'NHA, A'SA or A'OA; A : 1-5C alkyl; A' : 1-5C alkylene; Q1-Q3H, OH, CHO, COOH, halo, SH, sulfonyl, amino or amido, but Q2 is not amino; R1+R2oxo or thioxo. Independent claims are also included for: (1) a pharmaceutical composition comprising (I) and an excipient; and (2) the use of an azaspiro compound of formula (II) for producing a medicament for treating pain. [Image] X3, X4H; X3+X4S or NOH; R4, R5H, OH, CHO, COOH, halo, SH, sulfonyl, amino, amido or R10Q4; R4+R5oxo or thioxo; R6H, OH, amino or R11Q5; Z24- to 10-membered C-bonded ring that contains 0-2 O or S atoms and is optionally substituted with OH, CHO, COOH, halo, SH, sulfonyl, amino, amido or R12Q6; R10-R12A, 3-6C cycloalkyl, 2-5C alkenyl, 2-5C alkynyl, OA, COA, COOA, SA, NHA, SOA, SO2A, A'NHA, A'SA or A'OA; Q4-Q6H, OH, CHO, COOH, halo, SH, sulfonyl, amino or amido. All other definitions are as above. ACTIVITY : Analgesic; Antiinflammatory. 2-Azaspiro[4,6]undecane-3-thione gave an 83% reduction in foot licking over controls in the Wheeler-Aceto formalin test after 20-25 minutes at an intraperitoneal dose of 32 mg/kg, compared with 64% for gabapentin lactam. MECHANISM OF ACTION : None given.